Integra LifeSciences is a global medical technology leader dedicated to restoring lives. Headquartered in Princeton, New Jersey, we are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated gold-standard products and solutions is built on decades of clinical evidence and trusted by healthcare professionals to improve patient outcomes.
For the latest news and information about Integra and our products, visit www.integralife.com.
Each year, millions of people hear the words no one wants to hear: "You have cancer." And behind each diagnosis lies a unique story, a family that deserves hope, a future that's worth fighting for. We know that no two treatment journeys are the same and delivering care is far from simple. It's complex, urgent, and deeply human. That’s why we don’t back down from challenges—we rise to them. From the smallest tumor change to the toughest clinical decisions, we see every obstacle as an opportunity to progress. That is what drives us. The people undergoing treatment. The clinicians providing the care. We are united in purpose. Together, we can create a world where every patient has access to the highest standard of care. This is our commitment because for everyone, it's personal. We are leading the innovation in personalized radiation therapy solutions. We are Elekta.
Elekta reserves the right to remove any comment and to restrict access to its page at its sole discretion, without prior notice. The presence of user comments does not imply endorsement by Elekta, and Elekta makes no representations regarding the accuracy of such comments. User-generated content does not necessarily reflect the views, values, or positions of Elekta.
Uses amniotic membrane preserved with patented cryopreservation method to create a new generation of ocular surface tissue therapies designed to accelerate the regeneration of damaged tissue while reducing recipient discomfort associated with ocular surface reconstruction.
Bio-Tissue offers the only commercially available amniotic membrane that preserves the native integrity, activity, and function exhibited by the tissue in utero for ocular surface wound repair and wound healing. Our proprietary processing and preservation method retains vital cytokines and growth factors which facilitate healing mechanisms such as:
• Anti-inflammatory
• Anti-scarring
• Anti-angiogenic
• Pain reduction
• Promotion of epithelial healing